February 19, 2025 · Form 4 insider transaction
Mirviss Jeffrey B. sold 1,510 shares of Boston Scientific Corporation at $105.35 per share, a transaction worth $159.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.